Clinical study on the relationship between inflammatory factors and endothelial glycocalyx, microalbuminuria in patients with type 2 diabetic nephropathy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100042515

Enrollment

Unknown

Registered

2021-01-22

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

T2DM patients with normal microalbuminuria and normal fundus blood vessel examination vs. T2DN patients with elevated microalbuminuria and diabetic retinopathy:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. From March 2021 to February 2022, 300 patients with type 2 diabetes were diagnosed in our hospital; 2. T2DM patients with normal microalbuminuria and normal fundus blood vessel examination, T2DN patients with elevated microalbuminuria and diabetic retinopathy.

Exclusion criteria

Exclusion criteria: 1. Patients with acute inflammation and infection; 2. Subjects who have taken antiviral or antibiotic drugs in recent 3 months; 3. Patients with basic chronic nephritis, kidney disease, cancer, coronary heart disease or cardiac insufficiency.

Design outcomes

Primary

Measure	Time frame
IL-1ß;heparitin sulfate;syndecan-1;	—

Countries

China

Contacts

Public ContactLiqiong Jiang

Suzhou Hospital Affiliated to Nanjing Medical University

98qiong2008@163.com+86 13451974998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026